Patients diagnosed with nonobstructive coronary artery disease (CAD) are at increased risk of myocardial infarction (MI) and mortality over the next year compared with those classified as having no ...

It's been a difficult year for CardioDx, but there may be light at the end of the tunnel: In a new study, researchers found that the company's genetic test for coronary artery disease could help ...

In patients with CAD in more than 1 vessel, multiarterial CABG provides better survival and lower reintervention rates through 9 years of follow-up than does PCI, whether with DES or BMS. The findings ...

Prevencio unveiled promising results from a study investigating its multiprotein blood panel’s ability to predict the presence of obstructive coronary artery disease. The data could lead to better ...

Shockwave Medical Inc., a unit of Johnson & Johnson Medtech, reported positive 30-day results from the EMPOWER CAD trial, which used its intravascular lithotripsy system in women with complex, ...

A study by the Centre for Advanced Research in Imaging, Neuroscience and Genomics (CARING) found that AI powered CAD software can reduce hedging and defensive reporting statements in radiologist ...